Vincerx Pharma, Inc. Shareholders' Equity
Vincerx Pharma, Inc. had Shareholders' Equity of $2.07 million as of 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2025-05-15
- 2025-03-31: Stockholders' Equity Attributable to Parent $2.07M.
- 2024-12-31: Stockholders' Equity Attributable to Parent $2.72M.
- 2024-09-30: Stockholders' Equity Attributable to Parent $9.11M.
- 2024-06-30: Stockholders' Equity Attributable to Parent $15.45M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2025-03-31 | $2.07M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $2.72M 10-Q · filed 2025-05-15 | |
| 2024-09-30 | $9.11M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $15.45M 10-Q · filed 2024-11-12 | |
| 2024-03-31 | -$622.00K 10-Q · filed 2025-05-15 | |
| 2023-12-31 | $11.22M 10-Q · filed 2025-05-15 | |
| 2023-09-30 | $15.74M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $24.14M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $34.47M 10-Q · filed 2024-08-08 | |
| 2022-12-31 | $47.67M 10-K · filed 2025-03-27 | |
| 2022-09-30 | $59.71M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $74.36M 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $89.17M 10-Q · filed 2023-08-07 | |
| 2021-12-31 | $100.32M 10-K · filed 2024-03-29 | |
| 2021-09-30 | $100.63M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $71.59M 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $25.55M 10-Q · filed 2022-08-11 | |
| 2021-01-05 | $100.63M 10-Q · filed 2021-11-12 | |
| 2020-12-31 | $25.38M 10-K · filed 2023-03-28 | $57.69M 10-K · filed 2021-03-22 |
| 2020-09-30 | -$384.00K 10-Q · filed 2021-11-12 | $5.00M 10-Q · filed 2020-11-10 |
| 2020-06-30 | -$80.00K 10-Q · filed 2021-11-12 | $5.00M 10-K · filed 2020-09-23 |
| 2020-03-31 | -$48.00K 10-Q · filed 2021-08-12 | $5.00M 10-Q · filed 2020-05-06 |
| 2019-12-31 | -$44.00K 10-K · filed 2022-03-29 | $23.02K 10-Q · filed 2020-05-06 |
| 2019-09-30 | $23.45K 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $23.55K 10-Q · filed 2020-11-10 | |
| 2019-03-31 | $23.55K 10-Q · filed 2020-05-06 | |
| 2018-12-31 | -$1.45K 10-Q · filed 2020-05-06 |